Minor Histocompatibility AntigensTransplantation, HomologousHistocompatibility AntigensStem Cell TransplantationHematopoietic Stem Cell TransplantationStem CellsGraft vs Host DiseaseMajor Histocompatibility ComplexMinor Histocompatibility LociHLA AntigensTransplantation ConditioningHistocompatibility Antigens Class IIHistocompatibility Antigens Class IHistocompatibilityH-2 AntigensAntigensGraft vs Leukemia EffectHematologic NeoplasmsT-LymphocytesHematopoietic Stem CellsHistocompatibility TestingGraft vs Tumor EffectBone Marrow TransplantationH-Y AntigenTransplantation ChimeraT-Lymphocytes, CytotoxicAntigens, NeoplasmEmbryonic Stem CellsTissue DonorsAntigens, SurfaceLeukemiaVidarabineIsoantigensBusulfanPeripheral Blood Stem Cell TransplantationTransplantation ImmunologyAdult Stem CellsLymphocyte TransfusionCytotoxicity, ImmunologicRemission InductionAntigens, ViralMyeloablative AgonistsMice, Inbred C57BLRecurrenceTreatment OutcomeMice, Inbred StrainsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHLA-DR AntigensEpitopesGraft SurvivalAntigens, BacterialHLA-A AntigensCytomegalovirus InfectionsHLA-B AntigensMice, Inbred BALB CPluripotent Stem CellsCells, CulturedFlow CytometryAntibodies, MonoclonalGenes, MHC Class IILymphocyte ActivationSkin TransplantationLeukemia, Myeloid, AcuteHLA-A2 AntigenLymphocyte DepletionReceptors, Purinergic P2X5LymphocytesImmunosuppressive AgentsTransplantation, AutologousAntigens, CDHLA-B7 AntigenCell DifferentiationCD8-Positive T-LymphocytesLymphocyte Culture Test, MixedCell LineHLA-D AntigensStem Cell Nichebeta 2-MicroglobulinIsoantibodiesVirus ActivationGraft RejectionImmunogeneticsSpleenSiblingsMolecular Sequence DataCytotoxicity Tests, ImmunologicCytomegalovirusTime FactorsGraft vs Host ReactionHistocompatibility Antigen H-2DNeural Stem CellsAntilymphocyte SerumInduced Pluripotent Stem CellsB-LymphocytesAmino Acid SequenceNeoplasm, ResidualPrecursor Cell Lymphoblastic Leukemia-LymphomaReceptors, Antigen, T-CellMyelodysplastic SyndromesSalvage Therapy